These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35611842)

  • 1. Serum glial fibrillary acidic protein indicates memory impairment in patients with chronic heart failure.
    Traub J; Otto M; Sell R; Homola GA; Steinacker P; Oeckl P; Morbach C; Frantz S; Pham M; Störk S; Stoll G; Frey A
    ESC Heart Fail; 2022 Aug; 9(4):2626-2634. PubMed ID: 35611842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum phosphorylated tau protein 181 and neurofilament light chain in cognitively impaired heart failure patients.
    Traub J; Otto M; Sell R; Göpfert D; Homola G; Steinacker P; Oeckl P; Morbach C; Frantz S; Pham M; Störk S; Stoll G; Frey A
    Alzheimers Res Ther; 2022 Oct; 14(1):149. PubMed ID: 36217177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained Increase in Serum Glial Fibrillary Acidic Protein after First ST-Elevation Myocardial Infarction.
    Traub J; Grondey K; Gassenmaier T; Schmitt D; Fette G; Frantz S; Boivin-Jahns V; Jahns R; Störk S; Stoll G; Reiter T; Hofmann U; Weber MS; Frey A
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Glial Fibrillary Acidic Protein (GFAP) Is a Marker of Disease Severity in Frontotemporal Lobar Degeneration.
    Benussi A; Ashton NJ; Karikari TK; Gazzina S; Premi E; Benussi L; Ghidoni R; Rodriguez JL; Emeršič A; Binetti G; Fostinelli S; Giunta M; Gasparotti R; Zetterberg H; Blennow K; Borroni B
    J Alzheimers Dis; 2020; 77(3):1129-1141. PubMed ID: 32804092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of CSF, Plasma, and Imaging Markers of Neurodegeneration With Clinical Progression in People With Subjective Cognitive Decline.
    Ebenau JL; Pelkmans W; Verberk IMW; Verfaillie SCJ; van den Bosch KA; van Leeuwenstijn M; Collij LE; Scheltens P; Prins ND; Barkhof F; van Berckel BNM; Teunissen CE; van der Flier WM
    Neurology; 2022 Mar; 98(13):e1315-e1326. PubMed ID: 35110378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Levels of Glial Fibrillary Acidic Protein Association with Cognitive Impairment and Type 2 Diabetes.
    Ayala-Guerrero L; García-delaTorre P; Sánchez-García S; Guzmán-Ramos K
    Arch Med Res; 2022 Jul; 53(5):501-507. PubMed ID: 35794041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of plasma amyloid beta
    Verberk IMW; Thijssen E; Koelewijn J; Mauroo K; Vanbrabant J; de Wilde A; Zwan MD; Verfaillie SCJ; Ossenkoppele R; Barkhof F; van Berckel BNM; Scheltens P; van der Flier WM; Stoops E; Vanderstichele HM; Teunissen CE
    Alzheimers Res Ther; 2020 Sep; 12(1):118. PubMed ID: 32988409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiles of cognitive impairment in chronic heart failure-A cluster analytic approach.
    Göpfert D; Traub J; Sell R; Homola GA; Vogt M; Pham M; Frantz S; Störk S; Stoll G; Frey A
    Front Hum Neurosci; 2023; 17():1126553. PubMed ID: 37151899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remote Blood Biomarkers of Longitudinal Cognitive Outcomes in a Population Study.
    Rajan KB; Aggarwal NT; McAninch EA; Weuve J; Barnes LL; Wilson RS; DeCarli C; Evans DA
    Ann Neurol; 2020 Dec; 88(6):1065-1076. PubMed ID: 32799383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Glial Fibrillary Acidic Protein Predicts Tissue Glial Fibrillary Acidic Protein Break-Down Products and Therapeutic Efficacy after Penetrating Ballistic-Like Brain Injury.
    Boutté AM; Deng-Bryant Y; Johnson D; Tortella FC; Dave JR; Shear DA; Schmid KE
    J Neurotrauma; 2016 Jan; 33(1):147-56. PubMed ID: 25789543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum.
    Benedet AL; Milà-Alomà M; Vrillon A; Ashton NJ; Pascoal TA; Lussier F; Karikari TK; Hourregue C; Cognat E; Dumurgier J; Stevenson J; Rahmouni N; Pallen V; Poltronetti NM; Salvadó G; Shekari M; Operto G; Gispert JD; Minguillon C; Fauria K; Kollmorgen G; Suridjan I; Zimmer ER; Zetterberg H; Molinuevo JL; Paquet C; Rosa-Neto P; Blennow K; Suárez-Calvet M;
    JAMA Neurol; 2021 Dec; 78(12):1471-1483. PubMed ID: 34661615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study.
    Verberk IMW; Laarhuis MB; van den Bosch KA; Ebenau JL; van Leeuwenstijn M; Prins ND; Scheltens P; Teunissen CE; van der Flier WM
    Lancet Healthy Longev; 2021 Feb; 2(2):e87-e95. PubMed ID: 36098162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment.
    Cicognola C; Janelidze S; Hertze J; Zetterberg H; Blennow K; Mattsson-Carlgren N; Hansson O
    Alzheimers Res Ther; 2021 Mar; 13(1):68. PubMed ID: 33773595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glial fibrillary acidic protein as blood biomarker for differential diagnosis and severity of major depressive disorder.
    Steinacker P; Al Shweiki MR; Oeckl P; Graf H; Ludolph AC; Schönfeldt-Lecuona C; Otto M
    J Psychiatr Res; 2021 Dec; 144():54-58. PubMed ID: 34600287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of the glial fibrillary acidic protein and its breakdown products GFAP-BDP biomarker for the detection of traumatic brain injury compared to computed tomography and magnetic resonance imaging.
    McMahon PJ; Panczykowski DM; Yue JK; Puccio AM; Inoue T; Sorani MD; Lingsma HF; Maas AI; Valadka AB; Yuh EL; Mukherjee P; Manley GT; Okonkwo DO;
    J Neurotrauma; 2015 Apr; 32(8):527-33. PubMed ID: 25264814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity.
    Högel H; Rissanen E; Barro C; Matilainen M; Nylund M; Kuhle J; Airas L
    Mult Scler; 2020 Feb; 26(2):210-219. PubMed ID: 30570436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of serum glial fibrillary acidic protein and S100B serum levels in emergency medicine patients with traumatic versus nontraumatic intracerebral hemorrhage.
    Aydin I; Algin A; Poyraz MK; Yumrutas O
    Niger J Clin Pract; 2018 Dec; 21(12):1645-1650. PubMed ID: 30560830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis: GFAP and DTI.
    Saraste M; Bezukladova S; Matilainen M; Sucksdorff M; Kuhle J; Leppert D; Airas L
    Mult Scler Relat Disord; 2021 May; 50():102810. PubMed ID: 33556656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial fibrillary acidic protein as a prognostic marker of acute ischemic stroke.
    Liu G; Geng J
    Hum Exp Toxicol; 2018 Oct; 37(10):1048-1053. PubMed ID: 29308673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury.
    Robinson S; Winer JL; Berkner J; Chan LA; Denson JL; Maxwell JR; Yang Y; Sillerud LO; Tasker RC; Meehan WP; Mannix R; Jantzie LL
    J Neurosurg Pediatr; 2016 Jun; 17(6):739-55. PubMed ID: 26894518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.